BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11087237)

  • 21. Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice.
    Fujioka D; Saito Y; Kobayashi T; Yano T; Tezuka H; Ishimoto Y; Suzuki N; Yokota Y; Nakamura T; Obata JE; Kanazawa M; Kawabata K; Hanasaki K; Kugiyama K
    Circulation; 2008 Jun; 117(23):2977-85. PubMed ID: 18506007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury.
    Kupatt C; Habazettl H; Zahler S; Weber C; Becker BF; Messmer K; Gerlach E
    Cardiovasc Res; 1997 Dec; 36(3):386-95. PubMed ID: 9534860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase.
    Smith EF; Nichols AJ; Sellers TS; O'Brien SR; Griswold DE; Egan JW; Hillegass LM; Vasko JA; Slivjak MJ; Davis PA
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):729-38. PubMed ID: 1723770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation.
    Shen YC; Chen CF; Sung YJ
    Br J Pharmacol; 1999 Dec; 128(7):1593-601. PubMed ID: 10602341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selectin-targeting glycosaminoglycan-peptide conjugate limits neutrophil-mediated cardiac reperfusion injury.
    Dehghani T; Thai PN; Sodhi H; Ren L; Sirish P; Nader CE; Timofeyev V; Overton JL; Li X; Lam KS; Chiamvimonvat N; Panitch A
    Cardiovasc Res; 2022 Jan; 118(1):267-281. PubMed ID: 33125066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial protection by N,N,N-trimethylsphingosine in ischemia reperfusion injury is mediated by inhibition of P-selectin.
    Scalia R; Murohara T; Delyani JA; Nossuli TO; Lefer AM
    J Leukoc Biol; 1996 Mar; 59(3):317-24. PubMed ID: 8604008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury.
    Carter J; Buerke U; Rössner E; Russ M; Schubert S; Schmidt H; Ebelt H; Pruefer D; Schlitt A; Werdan K; Buerke M
    Br J Pharmacol; 2008 Sep; 155(1):93-102. PubMed ID: 18536753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.
    Buerke M; Prüfer D; Dahm M; Oelert H; Meyer J; Darius H
    J Pharmacol Exp Ther; 1998 Jul; 286(1):429-38. PubMed ID: 9655888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion.
    Hayward R; Nossuli TO; Scalia R; Lefer AM
    Eur J Pharmacol; 1997 Sep; 334(2-3):157-63. PubMed ID: 9369344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of endotoxin on neutrophil-mediated ischemia/reperfusion injury in the rat heart in vivo.
    Lipton BP; Delcarpio JB; McDonough KH
    Exp Biol Med (Maywood); 2001 Apr; 226(4):320-7. PubMed ID: 11368424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
    Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.
    Altavilla D; Deodato B; Campo GM; Arlotta M; Miano M; Squadrito G; Saitta A; Cucinotta D; Ceccarelli S; Ferlito M; Tringali M; Minutoli L; Caputi AP; Squadrito F
    Cardiovasc Res; 2000 Aug; 47(3):515-28. PubMed ID: 10963724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.
    Zhao ZQ; Corvera JS; Halkos ME; Kerendi F; Wang NP; Guyton RA; Vinten-Johansen J
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H579-88. PubMed ID: 12860564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of endotoxin on neutrophil-mediated I/R injury in isolated perfused rat hearts.
    Lipton BP; Bautista AP; Delcarpio JB; McDonough KH
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H802-11. PubMed ID: 11158980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes.
    Zhao ZQ; Nakamura M; Wang NP; Wilcox JN; Shearer S; Guyton RA; Vinten-Johansen J
    Coron Artery Dis; 1999 Dec; 10(8):617-28. PubMed ID: 10599541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
    Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetramethylpyrazine induces heme oxygenase-1 expression and attenuates myocardial ischemia/reperfusion injury in rats.
    Chen SY; Hsiao G; Hwang HR; Cheng PY; Lee YM
    J Biomed Sci; 2006 Sep; 13(5):731-40. PubMed ID: 16847723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.
    Montecucco F; Lenglet S; Braunersreuther V; Burger F; Pelli G; Bertolotto M; Mach F; Steffens S
    J Mol Cell Cardiol; 2009 May; 46(5):612-20. PubMed ID: 19162037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury.
    Jones SP; Trocha SD; Strange MB; Granger DN; Kevil CG; Bullard DC; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2196-201. PubMed ID: 11045953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
    Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
    J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.